Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
nobeastsofierce Shutterstock
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy). Read more
25 Nov 2024
Sawyer0/Adobe Stock
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). Read more
17 Oct 2024
Shutterstock
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
Portescap
How are drive systems for wearable and automatic drug delivery devices are central to the patient outcome?
Portescap’s business development manager for medical applications, Dave Beckstoffer, explains how drive systems for wearable and automatic drug delivery devices are central to the patient outcome. Read more
19 Dec 2024
Trong Nguyen Shutterstock
Securing the chain: The critical role of supply chain management in pharmaceutical packaging
Roel Winter, supply chain manager, Tjoapack discusses the critical role of supply chain management in pharmaceutical packaging. Read more
17 Dec 2024
ArisGlobal
Regulatory AI appetites are growing
ArisGlobal’s director of product management’s Agnes Cwienczek, reports on AI-boosted regulatory process automation and other top-level findings from a new Censuswide survey of senior life sciences regulatory professionals. Read more
16 Dec 2024
Purolite
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024 and what it meant for the company. Read more
13 Dec 2024
A9 STUDIO Shutterstock
How ready are you? Annex 1 and the impact of primary packaging
While it officially applies to the manufacture of sterile medicinal products in the European Union, the revised EU Good Manufacturing Practice (GMP) Annex 1 effectively reset the benchmark for quality standards across the globe. Read more
12 Dec 2024
Bruker Microbiology
Advanced microbial ID system accelerates product release testing
Stefan Karl, CEO, Mikrobiologisches Prüflabor, Innsbruck and Olaf Degen, director industry microbiology, Bruker Microbiology & Infection Diagnostics discuss how advanced microbial ID systems accelerate product release testing. Read more
10 Dec 2024
